These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17135590)

  • 1. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 2. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 3. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing of antiretroviral drugs during tuberculosis therapy.
    Wilson D; Meintjes G
    N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we be initiating antiretroviral therapy earlier? An argument in favour.
    Wood R
    S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for HIV Infection.
    Treat Guidel Med Lett; 2009 Feb; 7(78):11-22. PubMed ID: 19172137
    [No Abstract]   [Full Text] [Related]  

  • 7. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 8. Reconsidering early HIV treatment and supervised treatment interruptions.
    Koup RA
    PLoS Med; 2004 Nov; 1(2):e41. PubMed ID: 15578109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured treatment interruption for patients with human immunodeficiency virus infection.
    Roca B
    N Engl J Med; 2003 Dec; 349(23):2268-9; author reply 2268-9. PubMed ID: 14657438
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV therapy--what do we know, and when do we know it?
    Skolnik PR
    N Engl J Med; 2003 Dec; 349(24):2351-2. PubMed ID: 14668462
    [No Abstract]   [Full Text] [Related]  

  • 11. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 17. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 18. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a practical method to assess antiretroviral adherence in HIV-infected Thai children.
    Plipat N; Kottapat U; Komoltri C; Voradilokkul J; Anansakunwatt W; Chearskul P; Lapphra K; Phongsamart W; Chearskul S; Chokephaibulkit K; Vanprapar N
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):828-34. PubMed ID: 18041298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to initiate HIV therapy: a control theoretic approach.
    Jeffrey AM; Xia X; Craig IK
    IEEE Trans Biomed Eng; 2003 Nov; 50(11):1213-20. PubMed ID: 14619991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.